世界のアミフォスチン市場予測 2020年-2025年

【英語タイトル】Global Amifostine Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20AP4940)・商品コード:LPI20AP4940
・発行会社(調査会社):LP Information
・発行日:2020年3月27日(※2024年版があります。お問い合わせください)
・ページ数:138
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「アミフォスチンの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、400mg/用量、500mg/用量など、用途別には、頭頸部癌アジュバント療法、その他などに区分してまとめた調査レポートです。アミフォスチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・アミフォスチンの世界市場概要(サマリー)
・アミフォスチンの企業別販売量・売上
・アミフォスチンの企業別市場シェア
・アミフォスチンの世界市場規模 2015年-2020年:種類別(400mg/用量、500mg/用量)
・アミフォスチンの世界市場規模 2015年-2020年:用途別(頭頸部癌アジュバント療法、その他)
・アミフォスチンの米州市場規模(アメリカ、カナダ、メキシコなど)
・アミフォスチンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・アミフォスチンの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・アミフォスチンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・アミフォスチン市場の成長要因・課題・動向
・アミフォスチンの世界市場予測 2021年-2025年
・アミフォスチンの米州市場予測(アメリカ、カナダ、メキシコなど)
・アミフォスチンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・アミフォスチンの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・アミフォスチンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・アミフォスチンの世界市場予測:種類別(400mg/用量、500mg/用量)
・アミフォスチンの世界市場予測:用途別(頭頸部癌アジュバント療法、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Amifostine market will register a 2.3% CAGR in terms of revenue, the global market size will reach $ 54 million by 2025, from $ 49 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Amifostine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Amifostine market by type, application, key manufacturers and key regions and countries.

This study considers the Amifostine value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
400mg/Dose
500mg/Dose

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Head and Neck Cancer Adjuvant Therapy
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Clinigen
Sun Pharmaceutical
Merro Pharmaceutical
Luye Pharma
Taj Pharmaceuticals
Mingren Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Amifostine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Amifostine market by identifying its various subsegments.
Focuses on the key global Amifostine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Amifostine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Amifostine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Amifostine Consumption 2015-2025
2.1.2 Amifostine Consumption CAGR by Region
2.2 Amifostine Segment by Type
2.2.1 400mg/Dose
2.2.2 500mg/Dose
2.3 Amifostine Consumption by Type
2.3.1 Global Amifostine Consumption Market Share by Type (2015-2020)
2.3.2 Global Amifostine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Amifostine Sale Price by Type (2015-2020)
2.4 Amifostine Segment by Application
2.4.1 Head and Neck Cancer Adjuvant Therapy
2.4.2 Others
2.5 Amifostine Consumption by Application
2.5.1 Global Amifostine Consumption Market Share by Type (2015-2020)
2.5.2 Global Amifostine Value and Market Share by Type (2015-2020)
2.5.3 Global Amifostine Sale Price by Type (2015-2020)

3 Global Amifostine by Company
3.1 Global Amifostine Sales Market Share by Company
3.1.1 Global Amifostine Sales by Company (2018-2020)
3.1.2 Global Amifostine Sales Market Share by Company (2018-2020)
3.2 Global Amifostine Revenue Market Share by Company
3.2.1 Global Amifostine Revenue by Company (2018-2020)
3.2.2 Global Amifostine Revenue Market Share by Company (2018-2020)
3.3 Global Amifostine Sale Price by Company
3.4 Global Amifostine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Amifostine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Amifostine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Amifostine by Regions
4.1 Amifostine by Regions
4.2 Americas Amifostine Consumption Growth
4.3 APAC Amifostine Consumption Growth
4.4 Europe Amifostine Consumption Growth
4.5 Middle East & Africa Amifostine Consumption Growth

5 Americas
5.1 Americas Amifostine Consumption by Countries
5.1.1 Americas Amifostine Consumption by Countries (2015-2020)
5.1.2 Americas Amifostine Value by Countries (2015-2020)
5.2 Americas Amifostine Consumption by Type
5.3 Americas Amifostine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Amifostine Consumption by Regions
6.1.1 APAC Amifostine Consumption by Regions (2015-2020)
6.1.2 APAC Amifostine Value by Regions (2015-2020)
6.2 APAC Amifostine Consumption by Type
6.3 APAC Amifostine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Amifostine by Countries
7.1.1 Europe Amifostine Consumption by Countries (2015-2020)
7.1.2 Europe Amifostine Value by Countries (2015-2020)
7.2 Europe Amifostine Consumption by Type
7.3 Europe Amifostine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Amifostine by Countries
8.1.1 Middle East & Africa Amifostine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Amifostine Value by Countries (2015-2020)
8.2 Middle East & Africa Amifostine Consumption by Type
8.3 Middle East & Africa Amifostine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Amifostine Distributors
10.3 Amifostine Customer

11 Global Amifostine Market Forecast
11.1 Global Amifostine Consumption Forecast (2021-2025)
11.2 Global Amifostine Forecast by Regions
11.2.1 Global Amifostine Forecast by Regions (2021-2025)
11.2.2 Global Amifostine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Amifostine Forecast by Type
11.8 Global Amifostine Forecast by Application

12 Key Players Analysis
12.1 Clinigen
12.1.1 Company Information
12.1.2 Amifostine Product Offered
12.1.3 Clinigen Amifostine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Clinigen Latest Developments
12.2 Sun Pharmaceutical
12.2.1 Company Information
12.2.2 Amifostine Product Offered
12.2.3 Sun Pharmaceutical Amifostine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Sun Pharmaceutical Latest Developments
12.3 Merro Pharmaceutical
12.3.1 Company Information
12.3.2 Amifostine Product Offered
12.3.3 Merro Pharmaceutical Amifostine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Merro Pharmaceutical Latest Developments
12.4 Luye Pharma
12.4.1 Company Information
12.4.2 Amifostine Product Offered
12.4.3 Luye Pharma Amifostine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Luye Pharma Latest Developments
12.5 Taj Pharmaceuticals
12.5.1 Company Information
12.5.2 Amifostine Product Offered
12.5.3 Taj Pharmaceuticals Amifostine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Taj Pharmaceuticals Latest Developments
12.6 Mingren Pharma
12.6.1 Company Information
12.6.2 Amifostine Product Offered
12.6.3 Mingren Pharma Amifostine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Mingren Pharma Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Amifostine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 400mg/Dose
Table 5. Major Players of 500mg/Dose
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Amifostine Consumption Market Share by Type (2015-2020)
Table 8. Global Amifostine Revenue by Type (2015-2020) ($ million)
Table 9. Global Amifostine Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Amifostine Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Amifostine Consumption Market Share by Application (2015-2020)
Table 13. Global Amifostine Value by Application (2015-2020)
Table 14. Global Amifostine Value Market Share by Application (2015-2020)
Table 15. Global Amifostine Sale Price by Application (2015-2020)
Table 16. Global Amifostine Sales by Company (2017-2019) (MT)
Table 17. Global Amifostine Sales Market Share by Company (2017-2019)
Table 18. Global Amifostine Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Amifostine Revenue Market Share by Company (2017-2019)
Table 20. Global Amifostine Sale Price by Company (2017-2019)
Table 21. Global Amifostine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Amifostine Products Offered
Table 23. Amifostine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Amifostine Consumption by Regions 2015-2020 (MT)
Table 25. Global Amifostine Consumption Market Share by Regions 2015-2020
Table 26. Global Amifostine Value by Regions 2015-2020 ($ Millions)
Table 27. Global Amifostine Value Market Share by Regions 2015-2020
Table 28. Americas Amifostine Consumption by Countries (2015-2020) (MT)
Table 29. Americas Amifostine Consumption Market Share by Countries (2015-2020)
Table 30. Americas Amifostine Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Amifostine Value Market Share by Countries (2015-2020)
Table 32. Americas Amifostine Consumption by Type (2015-2020) (MT)
Table 33. Americas Amifostine Consumption Market Share by Type (2015-2020)
Table 34. Americas Amifostine Consumption by Application (2015-2020) (MT)
Table 35. Americas Amifostine Consumption Market Share by Application (2015-2020)
Table 36. APAC Amifostine Consumption by Countries (2015-2020) (MT)
Table 37. APAC Amifostine Consumption Market Share by Countries (2015-2020)
Table 38. APAC Amifostine Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Amifostine Value Market Share by Regions (2015-2020)
Table 40. APAC Amifostine Consumption by Type (2015-2020) (MT)
Table 41. APAC Amifostine Consumption Market Share by Type (2015-2020)
Table 42. APAC Amifostine Consumption by Application (2015-2020) (MT)
Table 43. APAC Amifostine Consumption Market Share by Application (2015-2020)
Table 44. Europe Amifostine Consumption by Countries (2015-2020) (MT)
Table 45. Europe Amifostine Consumption Market Share by Countries (2015-2020)
Table 46. Europe Amifostine Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Amifostine Value Market Share by Countries (2015-2020)
Table 48. Europe Amifostine Consumption by Type (2015-2020) (MT)
Table 49. Europe Amifostine Consumption Market Share by Type (2015-2020)
Table 50. Europe Amifostine Consumption by Application (2015-2020) (MT)
Table 51. Europe Amifostine Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Amifostine Consumption by Countries (2015-2020) (MT)
Table 53. Middle East & Africa Amifostine Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Amifostine Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Amifostine Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Amifostine Consumption by Type (2015-2020) (MT)
Table 57. Middle East & Africa Amifostine Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Amifostine Consumption by Application (2015-2020) (MT)
Table 59. Middle East & Africa Amifostine Consumption Market Share by Application (2015-2020)
Table 60. Amifostine Distributors List
Table 61. Amifostine Customer List
Table 62. Global Amifostine Consumption Forecast by Countries (2021-2025) (MT)
Table 63. Global Amifostine Consumption Market Forecast by Regions
Table 64. Global Amifostine Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Amifostine Value Market Share Forecast by Regions
Table 66. Global Amifostine Consumption Forecast by Type (2021-2025) (MT)
Table 67. Global Amifostine Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Amifostine Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Amifostine Value Market Share Forecast by Type (2021-2025)
Table 70. Global Amifostine Consumption Forecast by Application (2021-2025) (MT)
Table 71. Global Amifostine Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Amifostine Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Amifostine Value Market Share Forecast by Application (2021-2025)
Table 74. Clinigen Product Offered
Table 75. Clinigen Amifostine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 76. Clinigen Main Business
Table 77. Clinigen Latest Developments
Table 78. Clinigen Basic Information, Company Total Revenue (in $ million), Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sun Pharmaceutical Product Offered
Table 80. Sun Pharmaceutical Amifostine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 81. Sun Pharmaceutical Main Business
Table 82. Sun Pharmaceutical Latest Developments
Table 83. Sun Pharmaceutical Basic Information, Company Total Revenue (in $ million), Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 84. Merro Pharmaceutical Product Offered
Table 85. Merro Pharmaceutical Amifostine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 86. Merro Pharmaceutical Main Business
Table 87. Merro Pharmaceutical Latest Developments
Table 88. Merro Pharmaceutical Basic Information, Company Total Revenue (in $ million), Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 89. Luye Pharma Product Offered
Table 90. Luye Pharma Amifostine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 91. Luye Pharma Main Business
Table 92. Luye Pharma Latest Developments
Table 93. Luye Pharma Basic Information, Company Total Revenue (in $ million), Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 94. Taj Pharmaceuticals Product Offered
Table 95. Taj Pharmaceuticals Amifostine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 96. Taj Pharmaceuticals Main Business
Table 97. Taj Pharmaceuticals Latest Developments
Table 98. Taj Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 99. Mingren Pharma Product Offered
Table 100. Mingren Pharma Amifostine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 101. Mingren Pharma Main Business
Table 102. Mingren Pharma Latest Developments
Table 103. Mingren Pharma Basic Information, Company Total Revenue (in $ million), Amifostine Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Amifostine
Figure 2. Amifostine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Amifostine Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Amifostine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 400mg/Dose
Figure 7. Product Picture of 500mg/Dose
Figure 8. Global Amifostine Consumption Market Share by Type (2015-2020)
Figure 9. Global Amifostine Value Market Share by Type (2015-2020)
Figure 10. Amifostine Consumed in Head and Neck Cancer Adjuvant Therapy
Figure 11. Global Amifostine Market: Head and Neck Cancer Adjuvant Therapy (2015-2020) (MT)
Figure 12. Global Amifostine Market: Head and Neck Cancer Adjuvant Therapy (2015-2020) ($ Millions)
Figure 13. Amifostine Consumed in Others
Figure 14. Global Amifostine Market: Others (2015-2020) (MT)
Figure 15. Global Amifostine Market: Others (2015-2020) ($ Millions)
Figure 16. Global Amifostine Consumption Market Share by Application (2015-2020)
Figure 17. Global Amifostine Value Market Share by Application (2015-2020)
Figure 18. Global Amifostine Sales Market Share by Company in 2017
Figure 19. Global Amifostine Sales Market Share by Company in 2019
Figure 20. Global Amifostine Revenue Market Share by Company in 2017
Figure 21. Global Amifostine Revenue Market Share by Company in 2019
Figure 22. Global Amifostine Sale Price by Company in 2019
Figure 23. Global Amifostine Consumption Market Share by Regions 2015-2020
Figure 24. Global Amifostine Value Market Share by Regions 2015-2020
Figure 25. Americas Amifostine Consumption 2015-2020 (MT)
Figure 26. Americas Amifostine Value 2015-2020 ($ Millions)
Figure 27. APAC Amifostine Consumption 2015-2020 (MT)
Figure 28. APAC Amifostine Value 2015-2020 ($ Millions)
Figure 29. Europe Amifostine Consumption 2015-2020 (MT)
Figure 30. Europe Amifostine Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Amifostine Consumption 2015-2020 (MT)
Figure 32. Middle East & Africa Amifostine Value 2015-2020 ($ Millions)
Figure 33. Americas Amifostine Consumption Market Share by Countries in 2019
Figure 34. Americas Amifostine Value Market Share by Countries in 2019
Figure 35. Americas Amifostine Consumption Market Share by Type in 2019
Figure 36. Americas Amifostine Consumption Market Share by Application in 2019
Figure 37. United States Amifostine Consumption Growth 2015-2020 (MT)
Figure 38. United States Amifostine Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Amifostine Consumption Growth 2015-2020 (MT)
Figure 40. Canada Amifostine Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Amifostine Consumption Growth 2015-2020 (MT)
Figure 42. Mexico Amifostine Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Amifostine Consumption Market Share by Countries in 2019
Figure 44. APAC Amifostine Value Market Share by Regions in 2019
Figure 45. APAC Amifostine Consumption Market Share by Type in 2019
Figure 46. APAC Amifostine Consumption Market Share by Application in 2019
Figure 47. China Amifostine Consumption Growth 2015-2020 (MT)
Figure 48. China Amifostine Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Amifostine Consumption Growth 2015-2020 (MT)
Figure 50. Japan Amifostine Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Amifostine Consumption Growth 2015-2020 (MT)
Figure 52. Korea Amifostine Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Amifostine Consumption Growth 2015-2020 (MT)
Figure 54. Southeast Asia Amifostine Value Growth 2015-2020 ($ Millions)
Figure 55. India Amifostine Consumption Growth 2015-2020 (MT)
Figure 56. India Amifostine Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Amifostine Consumption Growth 2015-2020 (MT)
Figure 58. Australia Amifostine Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Amifostine Consumption Market Share by Countries in 2019
Figure 60. Europe Amifostine Value Market Share by Countries in 2019
Figure 61. Europe Amifostine Consumption Market Share by Type in 2019
Figure 62. Europe Amifostine Consumption Market Share by Application in 2019
Figure 63. Germany Amifostine Consumption Growth 2015-2020 (MT)
Figure 64. Germany Amifostine Value Growth 2015-2020 ($ Millions)
Figure 65. France Amifostine Consumption Growth 2015-2020 (MT)
Figure 66. France Amifostine Value Growth 2015-2020 ($ Millions)
Figure 67. UK Amifostine Consumption Growth 2015-2020 (MT)
Figure 68. UK Amifostine Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Amifostine Consumption Growth 2015-2020 (MT)
Figure 70. Italy Amifostine Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Amifostine Consumption Growth 2015-2020 (MT)
Figure 72. Russia Amifostine Value Growth 2015-2020 ($ Millions)
Figure 73. Spain Amifostine Consumption Growth 2015-2020 (MT)
Figure 74. Spain Amifostine Value Growth 2015-2020 ($ Millions)
Figure 75. Middle East & Africa Amifostine Consumption Market Share by Countries in 2019
Figure 76. Middle East & Africa Amifostine Value Market Share by Countries in 2019
Figure 77. Middle East & Africa Amifostine Consumption Market Share by Type in 2019
Figure 78. Middle East & Africa Amifostine Consumption Market Share by Application in 2019
Figure 79. Egypt Amifostine Consumption Growth 2015-2020 (MT)
Figure 80. Egypt Amifostine Value Growth 2015-2020 ($ Millions)
Figure 81. South Africa Amifostine Consumption Growth 2015-2020 (MT)
Figure 82. South Africa Amifostine Value Growth 2015-2020 ($ Millions)
Figure 83. Israel Amifostine Consumption Growth 2015-2020 (MT)
Figure 84. Israel Amifostine Value Growth 2015-2020 ($ Millions)
Figure 85. Turkey Amifostine Consumption Growth 2015-2020 (MT)
Figure 86. Turkey Amifostine Value Growth 2015-2020 ($ Millions)
Figure 87. GCC Countries Amifostine Consumption Growth 2015-2020 (MT)
Figure 88. GCC Countries Amifostine Value Growth 2015-2020 ($ Millions)
Figure 89. Global Amifostine Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 90. Global Amifostine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 91. Americas Amifostine Consumption 2021-2025 (MT)
Figure 92. Americas Amifostine Value 2021-2025 ($ Millions)
Figure 93. APAC Amifostine Consumption 2021-2025 (MT)
Figure 94. APAC Amifostine Value 2021-2025 ($ Millions)
Figure 95. Europe Amifostine Consumption 2021-2025 (MT)
Figure 96. Europe Amifostine Value 2021-2025 ($ Millions)
Figure 97. Middle East & Africa Amifostine Consumption 2021-2025 (MT)
Figure 98. Middle East & Africa Amifostine Value 2021-2025 ($ Millions)
Figure 99. United States Amifostine Consumption 2021-2025 (MT)
Figure 100. United States Amifostine Value 2021-2025 ($ Millions)
Figure 101. Canada Amifostine Consumption 2021-2025 (MT)
Figure 102. Canada Amifostine Value 2021-2025 ($ Millions)
Figure 103. Mexico Amifostine Consumption 2021-2025 (MT)
Figure 104. Mexico Amifostine Value 2021-2025 ($ Millions)
Figure 105. Brazil Amifostine Consumption 2021-2025 (MT)
Figure 106. Brazil Amifostine Value 2021-2025 ($ Millions)
Figure 107. China Amifostine Consumption 2021-2025 (MT)
Figure 108. China Amifostine Value 2021-2025 ($ Millions)
Figure 109. Japan Amifostine Consumption 2021-2025 (MT)
Figure 110. Japan Amifostine Value 2021-2025 ($ Millions)
Figure 111. Korea Amifostine Consumption 2021-2025 (MT)
Figure 112. Korea Amifostine Value 2021-2025 ($ Millions)
Figure 113. Southeast Asia Amifostine Consumption 2021-2025 (MT)
Figure 114. Southeast Asia Amifostine Value 2021-2025 ($ Millions)
Figure 115. India Amifostine Consumption 2021-2025 (MT)
Figure 116. India Amifostine Value 2021-2025 ($ Millions)
Figure 117. Australia Amifostine Consumption 2021-2025 (MT)
Figure 118. Australia Amifostine Value 2021-2025 ($ Millions)
Figure 119. Germany Amifostine Consumption 2021-2025 (MT)
Figure 120. Germany Amifostine Value 2021-2025 ($ Millions)
Figure 121. France Amifostine Consumption 2021-2025 (MT)
Figure 122. France Amifostine Value 2021-2025 ($ Millions)
Figure 123. UK Amifostine Consumption 2021-2025 (MT)
Figure 124. UK Amifostine Value 2021-2025 ($ Millions)
Figure 125. Italy Amifostine Consumption 2021-2025 (MT)
Figure 126. Italy Amifostine Value 2021-2025 ($ Millions)
Figure 127. Russia Amifostine Consumption 2021-2025 (MT)
Figure 128. Russia Amifostine Value 2021-2025 ($ Millions)
Figure 129. Spain Amifostine Consumption 2021-2025 (MT)
Figure 130. Spain Amifostine Value 2021-2025 ($ Millions)
Figure 131. Egypt Amifostine Consumption 2021-2025 (MT)
Figure 132. Egypt Amifostine Value 2021-2025 ($ Millions)
Figure 133. South Africa Amifostine Consumption 2021-2025 (MT)
Figure 134. South Africa Amifostine Value 2021-2025 ($ Millions)
Figure 135. Israel Amifostine Consumption 2021-2025 (MT)
Figure 136. Israel Amifostine Value 2021-2025 ($ Millions)
Figure 137. Turkey Amifostine Consumption 2021-2025 (MT)
Figure 138. Turkey Amifostine Value 2021-2025 ($ Millions)
Figure 139. GCC Countries Amifostine Consumption 2021-2025 (MT)
Figure 140. GCC Countries Amifostine Value 2021-2025 ($ Millions)
Figure 141. Clinigen Amifostine Market Share (2018-2020)
Figure 142. Sun Pharmaceutical Amifostine Market Share (2018-2020)
Figure 143. Merro Pharmaceutical Amifostine Market Share (2018-2020)
Figure 144. Luye Pharma Amifostine Market Share (2018-2020)
Figure 145. Taj Pharmaceuticals Amifostine Market Share (2018-2020)
Figure 146. Mingren Pharma Amifostine Market Share (2018-2020)


★調査レポート[世界のアミフォスチン市場予測 2020年-2025年] (コード:LPI20AP4940)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアミフォスチン市場予測 2020年-2025年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆